Paper21331069
The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
Occhionorelli M and 15 others. Leukemia, 2011. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha. Papers, record 21331069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21331069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Leukemia, Promyelocytic, Acute | Major topic |
| Nuclear Proteins | Major topic |
| Receptors, Retinoic Acid | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Transcription Factors | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Animals | |
| Blotting, Western | |
| Chromatography, Gel | |
| Fluorescent Antibody Technique | |
| Hematopoietic Stem Cells | |
| Immunophenotyping | |
| Immunoprecipitation | |
| Mice | |
| Promyelocytic Leukemia Protein | |
| Protein Multimerization | |
| RNA, Messenger | |
| Retinoic Acid Receptor alpha | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16473277 | Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16473277 | PubMed |
| 2 | 8890168 | Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. | EMBO J | 1996 | https://conductscience.org/library/papers/8890168 | PubMed |
| 3 | 17613434 | RXR is an essential component of the oncogenic PML/RARA complex in vivo. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17613434 | PubMed |
| 4 | 10597230 | Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. | Oncogene | 1999 | https://conductscience.org/library/papers/10597230 | PubMed |
| 5 | 15710327 | A sumoylation site in PML/RARA is essential for leukemic transformation. | Cancer Cell | 2005 | https://conductscience.org/library/papers/15710327 | PubMed |
| 6 | 16449642 | Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16449642 | PubMed |
| 7 | 16473276 | Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16473276 | PubMed |
| 8 | 8562957 | The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. | Blood | 1996 | https://conductscience.org/library/papers/8562957 | PubMed |
| 9 | 11834837 | Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. | Science | 2002 | https://conductscience.org/library/papers/11834837 | PubMed |
| 10 | 9122233 | A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9122233 | PubMed |
| 11 | 12351412 | PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors. | Blood | 2002 | https://conductscience.org/library/papers/12351412 | PubMed |
| 12 | 1652369 | The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. | Cell | 1991 | https://conductscience.org/library/papers/1652369 | PubMed |
| 13 | 18469801 | PML targeting eradicates quiescent leukaemia-initiating cells. | Nature | 2008 | https://conductscience.org/library/papers/18469801 | PubMed |
| 14 | 1652368 | Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. | Cell | 1991 | https://conductscience.org/library/papers/1652368 | PubMed |
| 15 | 17613435 | Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17613435 | PubMed |
| 16 | 9426049 | High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. | Cancer Res | 1998 | https://conductscience.org/library/papers/9426049 | PubMed |
| 17 | 10441338 | The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. | Hum Mol Genet | 1999 | https://conductscience.org/library/papers/10441338 | PubMed |
| 18 | 1319828 | Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. | Cancer Res | 1992 | https://conductscience.org/library/papers/1319828 | PubMed |
| 19 | 12750176 | High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. | Blood | 2003 | https://conductscience.org/library/papers/12750176 | PubMed |
| 20 | 8248779 | A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. | Science | 1993 | https://conductscience.org/library/papers/8248779 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42663568 | PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization. | J Exp Med | 2026 | https://conductscience.org/library/papers/42663568 | PubMed |
| 40330660 | Mutation in the Unrearranged PML Allele Confers Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40330660 | PubMed |
| 38611029 | History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38611029 | PubMed |
| 38503502 | Acute Promyelocytic Leukemia, Retinoic Acid, and Arsenic: A Tale of Dualities. | Cold Spring Harb Perspect Med | 2024 | https://conductscience.org/library/papers/38503502 | PubMed |
| 38069029 | PML Body Biogenesis: A Delicate Balance of Interactions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069029 | PubMed |
| 37139432 | AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37139432 | PubMed |
| 35957886 | Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. | Front Oncol | 2022 | https://conductscience.org/library/papers/35957886 | PubMed |
| 35399865 | PML nuclear body biogenesis and oligomerization-driven leukemogenesis. | Blood Sci | 2020 | https://conductscience.org/library/papers/35399865 | PubMed |
| 32700196 | Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia. | Oncol Ther | 2019 | https://conductscience.org/library/papers/32700196 | PubMed |
| 31439836 | B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis. | Nat Commun | 2019 | https://conductscience.org/library/papers/31439836 | PubMed |
| 30674471 | FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. | Blood | 2019 | https://conductscience.org/library/papers/30674471 | PubMed |
| 29192213 | Differentiation therapy revisited. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29192213 | PubMed |
| 29191918 | Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. | Blood | 2018 | https://conductscience.org/library/papers/29191918 | PubMed |
| 26637438 | p53 as an Effector or Inhibitor of Therapy Response. | Cold Spring Harb Perspect Med | 2015 | https://conductscience.org/library/papers/26637438 | PubMed |
| 26088929 | Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. | Haematologica | 2015 | https://conductscience.org/library/papers/26088929 | PubMed |
| 25092303 | The PML domain of PML-RARα blocks senescence to promote leukemia. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25092303 | PubMed |
| 24183235 | Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade. | Leuk Res | 2013 | https://conductscience.org/library/papers/24183235 | PubMed |
| 23847764 | Is PML a Tumor Suppressor? | Front Oncol | 2013 | https://conductscience.org/library/papers/23847764 | PubMed |
| 22935026 | Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation. | Biochemistry | 2012 | https://conductscience.org/library/papers/22935026 | PubMed |
| 22778276 | The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies. | J Cell Biol | 2012 | https://conductscience.org/library/papers/22778276 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PML | 5371 | PubTator's text mining | https://conductscience.org/library/genes/5371 | NCBI Gene |
| RARA | 5914 | PubTator's text mining | https://conductscience.org/library/genes/5914 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21331069
GET https://conductscience.org/api/papers/v1/21331069/references?page=2